glp-1 agonist indications The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Transformation 2.0: The GLP-1 RAs

Sivalingam S, Wasehuus VS, Rotbain Curovic V, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Yanovski J.A., Krakoff J., Salaita C.G., McDuffie J.R., Kozlosky M., Sebring N.G., Reynolds J.C., Brady S.M., Calis K.A

Lizard-linked therapy has roots in the Bronx

Novo Nordisk offers similar programs for Wegovy

43 Therefore, discontinuation of treatmentprimarily due to cost and access limitationsremains the major barrier to the widespread and sustainable use of these agents

There is also preclinical evidence that GLP-1RAs may directly modulate pain through reduction of central sensitization, suggesting the possibility of additional symptomatic improvement for IIH patients with headache (32)